---
title: "Tofogliflozin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: tofogliflozindiabetesmellitustype2.html
toc: false 
---

{% include image.html url="images/tofogliflozindiabetesmellitustype2.png" file="tofogliflozindiabetesmellitustype2.png" alt="tofogliflozindiabetesmellitustype2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C575086 | Tofogliflozin | Drug |
| UniProt:P31639 | SGLT2 | Protein |
| GO:0035623 | Renal glucose absorption | BiologicalProcess |
| MESH:D001786 | Blood Glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tofogliflozin | DECREASES ACTIVITY OF | Sglt2 |
| Sglt2 | PREVENTS | Renal Glucose Absorption |
| Renal Glucose Absorption | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB11824#mechanism-of-action](https://go.drugbank.com/drugs/DB11824#mechanism-of-action){:target="_blank"}